LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 48

Search options

  1. Article ; Online: Critical Involvement of CD44 in T Helper Type 2 Cell-Mediated Eosinophilic Airway Inflammation in a Mouse Model of Acute Asthma.

    Katoh, Shigeki

    Frontiers in immunology

    2022  Volume 12, Page(s) 811600

    Abstract: Interactions between CD44 and hyaluronan (HA) are crucial for recruiting leukocytes to inflamed tissues. This review summarizes findings from our studies of the roles of CD44-HA interactions in leukocyte trafficking, with a particular focus on airway T ... ...

    Abstract Interactions between CD44 and hyaluronan (HA) are crucial for recruiting leukocytes to inflamed tissues. This review summarizes findings from our studies of the roles of CD44-HA interactions in leukocyte trafficking, with a particular focus on airway T helper type 2 (Th2) cells in mouse models of acute asthma. In a mite allergen-induced model of acute asthma, intraperitoneal injection of anti-CD44 monoclonal antibodies blocked lymphocytes and eosinophils from accumulating in the lung, and suppressed both the antigen-induced increase in Th2 cytokines in the bronchoalveolar lavage fluid (BALF) and airway hyperresponsiveness (AHR). CD44 deficiency was associated with decreased mite allergen-induced Th2 cell-mediated airway inflammation and AHR in sensitized mice. Asthmatic responses to antigen-sensitized splenic CD4
    MeSH term(s) Allergens/immunology ; Animals ; Asthma/etiology ; Asthma/metabolism ; Asthma/pathology ; Biomarkers ; Cytokines/metabolism ; Disease Models, Animal ; Disease Susceptibility ; Eosinophils/immunology ; Eosinophils/metabolism ; Glycosylation ; Humans ; Hyaluronan Receptors/metabolism ; Hyaluronic Acid/metabolism ; Immunization ; Inflammation Mediators/metabolism ; Mice, Knockout ; T-Lymphocyte Subsets/immunology ; T-Lymphocyte Subsets/metabolism ; Th2 Cells/immunology ; Th2 Cells/metabolism ; Mice
    Chemical Substances Allergens ; Biomarkers ; CD44 protein, human ; Cytokines ; Hyaluronan Receptors ; Inflammation Mediators ; Hyaluronic Acid (9004-61-9)
    Language English
    Publishing date 2022-01-07
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 2606827-8
    ISSN 1664-3224 ; 1664-3224
    ISSN (online) 1664-3224
    ISSN 1664-3224
    DOI 10.3389/fimmu.2021.811600
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Analysis of the relationship between comorbid obstructive sleep apnea and clinical outcomes in patients with asthma in Japan.

    Ikegami-Tanaka, Hitomi / Yasokawa, Naoya / Kurose, Koji / Tajima, Shonosuke / Abe, Masaaki / Katoh, Shigeki / Kobashi, Yoshihiro / Oga, Toru

    Allergology international : official journal of the Japanese Society of Allergology

    2024  

    Abstract: Background: Asthma and obstructive sleep apnea (OSA) are prevalent chronic respiratory disorders, which often coexist and interact with each other. Obesity is an important risk factor shared by them. The rate of obesity is lower in Japan versus Western ... ...

    Abstract Background: Asthma and obstructive sleep apnea (OSA) are prevalent chronic respiratory disorders, which often coexist and interact with each other. Obesity is an important risk factor shared by them. The rate of obesity is lower in Japan versus Western countries. Hence, the co-existence of asthma and OSA has not been investigated in Japan.
    Methods: Ninety-seven outpatients with asthma were recruited. Patients wore a portable monitor for sleep study. Background data, pulmonary function, blood tests, and patient-reported outcomes including gastroesophageal reflux disease, sleepiness, sleep quality, asthma control, cough and respiratory symptoms, and health status, were assessed.
    Results: Of the patients, 19 (19.6 %), 40 (41.2 %), 24 (24.7 %), and 14 (14.4 %) were classified into non-, mild, moderate, and severe OSA groups. Non-OSA patients were younger than those in other groups (p < 0.05). The BMI of patients with moderate and severe OSA, was higher than that of non-OSA patients (p < 0.05). Pulmonary function, FeNO, serum IgE, and the number of peripheral eosinophils were not significantly different between groups. Nonetheless, compared with the other groups, treatment step was the highest, and the Asthma Control Test, Leicester Cough Questionnaire, COPD Assessment Test, and Asthma Health Questionnaire-33 yielded worst scores in the severe OSA group, and predicted the severe OSA after adjustment by BMI.
    Conclusions: Moderate and severe OSA are highly prevalent among patients with asthma in Japan. Pulmonary function did not differ between groups. However, patients with asthma and severe OSA were linked to more asthma treatment, worse asthma control, more symptoms and cough, and worse health status.
    Language English
    Publishing date 2024-02-09
    Publishing country England
    Document type Journal Article
    ZDB-ID 1336498-4
    ISSN 1440-1592 ; 1323-8930
    ISSN (online) 1440-1592
    ISSN 1323-8930
    DOI 10.1016/j.alit.2024.01.009
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Role of interleukin 5-induced eosinophils in interleukin 33-triggered airway inflammation in mice.

    Tanaka, Hitomi / Katoh, Shigeki / Uno, Kazuko / Oga, Toru

    Asian Pacific journal of allergy and immunology

    2021  

    Abstract: Background: Interleukin (IL)-5 is essential for allergen induced eosinophilic airway inflammation, but not activation of T helper type 2 (Th2) cells in the lung. Although an excessive Th2 reaction is observed without IL-5 signaling, the mechanisms have ... ...

    Abstract Background: Interleukin (IL)-5 is essential for allergen induced eosinophilic airway inflammation, but not activation of T helper type 2 (Th2) cells in the lung. Although an excessive Th2 reaction is observed without IL-5 signaling, the mechanisms have remained unknown.
    Objective: To evaluate the negative-feedback mechanism in eosinophilic airway inflammation, we examined IL-33 triggered eosinophilic airway inflammation in IL-5Rα-/- mice.
    Methods: Mice were administered intranasal IL-33 for 3 days. Airway hyperresponsiveness (AHR) was evaluated and bronchoalveolar lavage (BAL) was performed 24 h after the last IL-33 treatment. The number of inflammatory cells and cytokine levels in the BAL fluid (BALF) were analyzed, and histologic examination was performed.
    Results: Compared with IL-33 treated wild-type (WT) mice, intranasal administration of IL-33 in IL-5Rα-/- mice reduced eosinophilic airway inflammation, AHR, and basement membrane thickening, while we found excessive IL-33 induced IL-5 and IL-13 production in the airway without IL-5 signaling. The numbers of eosinophils with a ringshaped nucleus (resident) and segmented nucleus (inflammatory) were increased in WT mice, but not in IL-5Rα-/- mice following intranasal administration of IL-33, and the numbers of SiglecF-positive eosinophils with (resident) or without (inflammatory) expression of CD62L were also significantly increased by IL-33 treatment in WT mice, but not in IL5Rα-/- mice. The number of ILC2 cells in the BALF was significantly higher in IL-33 treated IL-5Rα-/- mice than in IL-33 treated WT mice.
    Conclusions: These findings suggest the possibility that IL-5 induced eosinophils contribute to the negative-feedback mechanisms in IL-33 induced ILC2 mediated airway inflammation.
    Language English
    Publishing date 2021-12-26
    Publishing country Thailand
    Document type Journal Article
    ZDB-ID 605782-2
    ISSN 2228-8694 ; 0125-877X
    ISSN (online) 2228-8694
    ISSN 0125-877X
    DOI 10.12932/AP-120821-1208
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: CD44 is critical for the enhancing effect of hyaluronan in allergen-specific sublingual immunotherapy in a murine model of chronic asthma.

    Katoh, Shigeki / Uesaka, Tae / Tanaka, Hitomi / Matsuhara, Hiroki / Ohashi-Doi, Katsuyo / Oga, Toru

    Clinical and experimental immunology

    2022  Volume 208, Issue 2, Page(s) 202–211

    Abstract: Allergen-specific sublingual immunotherapy (SLIT) is a potentially effective disease-modification treatment for patients with allergic asthma. Because CD44 signaling enhances regulatory T (Treg) cell-induction, administering CD44 ligands such as ... ...

    Abstract Allergen-specific sublingual immunotherapy (SLIT) is a potentially effective disease-modification treatment for patients with allergic asthma. Because CD44 signaling enhances regulatory T (Treg) cell-induction, administering CD44 ligands such as hyaluronan (HA) with allergen-specific SLIT may enhance the therapeutic effects. We evaluated the role of CD44 in Treg cell-induction in T helper type 2 (Th2)-mediated chronic airway inflammation using CD44-/- mice and the efficacy of HA on SLIT in a Dermatophagoides farinae (Df)-induced murine model of chronic asthma. Th2 responses and Treg cell induction were evaluated in CD44-/- mice. We devised a new SLIT model of Df-induced chronic asthma utilizing HA as an adjuvant. The effects of HA added to the new SLIT model were evaluated by the early asthmatic response (EAR) and airway hyperresponsiveness (AHR), eosinophilic airway inflammation, and serum Df-specific IgE levels. Th2-mediated chronic eosinophilic airway inflammation was worse in CD44-/- mice compared with Df-sensitized wild-type (WT) mice. HA enhanced the effect of Df-induced Treg cells in a CD44-dependent manner. Sublingual Df treatment in combination with HA, but not alone, normalized EAR and AHR, and significantly reduced the serum IgE levels and the bronchoalveolar lavage fluid (BALF) eosinophil number. HA also induced Treg cells in a Df-sensitized spleen cell culture in a CD44-dependent manner. The treatment-enhancing effects of HA in this SLIT model were diminished in CD44-/- mice. CD44 is a key contributor to Treg cell induction and critical for the enhancing effects of HA in a Df-induced murine model of chronic asthma.
    MeSH term(s) Allergens ; Animals ; Asthma/therapy ; Bronchoalveolar Lavage Fluid ; Disease Models, Animal ; Humans ; Hyaluronan Receptors ; Hyaluronic Acid ; Immunoglobulin E ; Inflammation ; Mice ; Mice, Inbred BALB C ; Mice, Knockout ; Sublingual Immunotherapy
    Chemical Substances Allergens ; Cd44 protein, mouse ; Hyaluronan Receptors ; Immunoglobulin E (37341-29-0) ; Hyaluronic Acid (9004-61-9)
    Language English
    Publishing date 2022-04-28
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 218531-3
    ISSN 1365-2249 ; 0009-9104 ; 0964-2536
    ISSN (online) 1365-2249
    ISSN 0009-9104 ; 0964-2536
    DOI 10.1093/cei/uxac024
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: A recurrent case of eosinophilic pneumonia with high IL-25 levels.

    Ikeda, Masaki / Katoh, Shigeki / Oka, Mikio

    Allergology international : official journal of the Japanese Society of Allergology

    2018  Volume 67S, Page(s) S38–S40

    MeSH term(s) Aged ; Biomarkers ; Bronchoalveolar Lavage Fluid ; Female ; Humans ; Interleukin-17/blood ; Interleukin-17/metabolism ; Pulmonary Eosinophilia/blood ; Pulmonary Eosinophilia/diagnosis ; Pulmonary Eosinophilia/metabolism ; Radiography, Thoracic ; Recurrence ; Tomography, X-Ray Computed
    Chemical Substances Biomarkers ; IL25 protein, human ; Interleukin-17
    Language English
    Publishing date 2018-05-18
    Publishing country England
    Document type Case Reports ; Letter
    ZDB-ID 1336498-4
    ISSN 1440-1592 ; 1323-8930
    ISSN (online) 1440-1592
    ISSN 1323-8930
    DOI 10.1016/j.alit.2018.03.005
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Real-world efficacy of anti-IL-5 treatment in patients with allergic bronchopulmonary aspergillosis.

    Tomomatsu, Katsuyoshi / Yasuba, Hirotaka / Ishiguro, Takashi / Imokawa, Shiro / Hara, Johsuke / Soeda, Seiko / Harada, Norihiro / Tsurikisawa, Naomi / Oda, Naohiro / Katoh, Shigeki / Numata, Takanori / Sugino, Yasuteru / Yamada, Mitsuhiro / Kamimura, Mitsuhiro / Terashima, Takeshi / Okada, Naoki / Tanaka, Jun / Oguma, Tsuyoshi / Asano, Koichiro

    Scientific reports

    2023  Volume 13, Issue 1, Page(s) 5468

    Abstract: Despite standard treatment with systemic corticosteroids and/or antifungal triazoles, a substantial proportion of patients with allergic bronchopulmonary aspergillosis (ABPA) experience frequent relapses and require long-term treatment despite ... ...

    Abstract Despite standard treatment with systemic corticosteroids and/or antifungal triazoles, a substantial proportion of patients with allergic bronchopulmonary aspergillosis (ABPA) experience frequent relapses and require long-term treatment despite unfavorable adverse effects. We investigated the efficacy and safety of anti-interleukin (IL)-5/IL-5 receptor α chain (Rα) monoclonal antibodies (mAbs) in patients with ABPA complicated by asthma. ABPA cases treated with anti-IL-5/IL-5Rα mAbs were collected from 132 medical institutes in 2018 and published case reports in Japan. Clinical outcomes, laboratory and physiological data, and radiographic findings during 32 weeks before and after treatment were retrospectively evaluated. We analyzed 29 cases of ABPA: 20 treated with mepolizumab and nine with benralizumab. Treatment with anti-IL-5/IL-5Rα mAbs reduced the frequency of exacerbations (p = 0.03), decreased the dose of oral corticosteroids (p < 0.01), and improved pulmonary function (p = 0.01). Mucus plugs in the bronchi shrank or diminished in 18 patients (82%). Despite the clinical/radiographical improvement, serum levels of total IgE, the key biomarker for the pharmacological response in ABPA, were unchanged. Anti-IL-5/IL-5Rα mAbs that directly target eosinophils are promising candidates for the treatment of patients with ABPA, especially those with mucus plugs in the bronchi.
    MeSH term(s) Humans ; Aspergillosis, Allergic Bronchopulmonary/drug therapy ; Retrospective Studies ; Asthma/etiology ; Antifungal Agents/therapeutic use ; Adrenal Cortex Hormones/therapeutic use ; Antibodies, Monoclonal/therapeutic use
    Chemical Substances Antifungal Agents ; Adrenal Cortex Hormones ; Antibodies, Monoclonal
    Language English
    Publishing date 2023-04-04
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2615211-3
    ISSN 2045-2322 ; 2045-2322
    ISSN (online) 2045-2322
    ISSN 2045-2322
    DOI 10.1038/s41598-023-32246-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Beneficial effects of Galectin-9 on allergen-specific sublingual immunotherapy in a Dermatophagoides farinae-induced mouse model of chronic asthma.

    Ikeda, Masaki / Katoh, Shigeki / Shimizu, Hiroki / Hasegawa, Akira / Ohashi-Doi, Katsuyo / Oka, Mikio

    Allergology international : official journal of the Japanese Society of Allergology

    2017  Volume 66, Issue 3, Page(s) 432–439

    Abstract: Background: Allergen-specific sublingual immunotherapy is a potential disease-modifying treatment for allergic asthma. Galectin-9 (Gal-9), a β-galactoside-binding protein with various biologic effects, acts as an immunomodulator in excessive immunologic ...

    Abstract Background: Allergen-specific sublingual immunotherapy is a potential disease-modifying treatment for allergic asthma. Galectin-9 (Gal-9), a β-galactoside-binding protein with various biologic effects, acts as an immunomodulator in excessive immunologic reactions by expanding regulatory T cells (Treg) and enhancing transforming growth factor (TGF)-β signaling. We investigated the efficacy of sublingually administered Gal-9 as an adjuvant to a specific allergen in a Dermatophagoides farinae (Df)-induced mouse model of chronic asthma.
    Methods: BALB/c mice were intranasally sensitized with Df extract 5 days/week for 5 weeks, and then sublingual Df-allergen extract for 2 weeks (5 days/week). Three days after the final sublingual treatment, mice were intranasally challenged with Df extract. The early asthmatic response (EAR) was evaluated 5 min after the last Df challenge. Airway hyperresponsiveness (AHR) was assayed and bronchoalveolar lavage (BAL) was performed 24 h after the last allergen challenge. Serum IgE and cytokine levels, and number of inflammatory cells in the BAL fluid (BALF) were analyzed.
    Results: Sublingual Df treatment in the presence of Gal-9, but not alone, significantly reduced AHR; EAR; number of eosinophils and interleukin-13 in the BALF; and serum IgE levels. BALF TGF-β1 levels were significantly increased in the presence of Gal-9 compared with Df alone. Treg depletion blocked the inhibitory effects of Gal-9 on the EAR, AHR, eosinophilic airway inflammation, and Df-specific serum IgE levels, and suppressed BALF TGF-β1 levels.
    Conclusions: Gal-9 exhibited beneficial effects of sublingual Df allergen-specific immunotherapy in a Df-induced mouse model of chronic asthma, possibly by Gal-9-induced TGF-β1 production in the lung.
    Language English
    Publishing date 2017-07
    Publishing country England
    Document type Journal Article
    ZDB-ID 1336498-4
    ISSN 1440-1592 ; 1323-8930
    ISSN (online) 1440-1592
    ISSN 1323-8930
    DOI 10.1016/j.alit.2016.10.007
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Biomarkers for differentiation of patients with asthma and chronic obstructive pulmonary disease.

    Katoh, Shigeki / Ikeda, Masaki / Shirai, Ryo / Abe, Masaaki / Ohue, Yoshihiro / Kobashi, Yoshihiro / Oka, Mikio

    The Journal of asthma : official journal of the Association for the Care of Asthma

    2017  Volume 55, Issue 10, Page(s) 1052–1058

    Abstract: Objective: Asthma and chronic obstructive pulmonary disease (COPD) are airflow limitation diseases with similar clinical manifestations but different pathophysiologic mechanisms. To implement the appropriate treatment, it is important to distinguish ... ...

    Abstract Objective: Asthma and chronic obstructive pulmonary disease (COPD) are airflow limitation diseases with similar clinical manifestations but different pathophysiologic mechanisms. To implement the appropriate treatment, it is important to distinguish between asthma and COPD which sometimes might result difficult in clinical practice. We evaluated biomarkers to distinguish between asthma and COPD.
    Methods: Blood eosinophil counts and fractional exhaled nitric oxide (FeNO) levels were analyzed. Serum periostin, interleukin-25 (IL-25), and immunoglobulin E (IgE) concentrations were compared between patients with asthma (n = 60), including atopic-asthma (n = 30) and non-atopic asthma (n = 30), and patients with COPD (n = 30).
    Results: Significantly higher peripheral blood eosinophil counts (p < 0.001), FeNO levels (p < 0.001), and total serum IgE (P = 0.003) concentrations, but not serum periostin (p = 0.584) or serum IL-25 (p = 0.085) concentrations, were detected in patients with asthma compared to patients with COPD. Serum periostin and IgE concentrations were increased in patients with atopic-asthma compared with those with non-atopic asthma and COPD (p < 0.05). The FeNO levels were significantly correlated with the peripheral blood eosinophil counts (r = 0.430, p = 0.001) and serum IL-25 concentrations (r = 0.338, p = 0.009) in patients with asthma. The serum periostin concentrations were also correlated with the serum IgE concentrations (r = 0.375, p = 0.003)and FeNO levels (r = 0.291, p = 0.024) in patients with asthma. Asthma patients were effectively differentiated from COPD patients based on the FeNO levels (p < 0.001) and peripheral blood eosinophil counts (p < 0.001).
    Conclusions: FeNO levels and peripheral blood eosinophil counts were useful biomarkers for distinguishing between patients with asthma and COPD. Serum periostin and IgE concentrations could be biomarkers for atopic asthma.
    MeSH term(s) Adult ; Age Factors ; Aged ; Aged, 80 and over ; Asthma/blood ; Asthma/diagnosis ; Asthma/epidemiology ; Biomarkers ; Cell Adhesion Molecules/blood ; Diagnosis, Differential ; Eosinophils/metabolism ; Female ; Humans ; Hypersensitivity, Immediate/blood ; Hypersensitivity, Immediate/epidemiology ; Immunoglobulin E/blood ; Interleukin-17/blood ; Male ; Middle Aged ; Nitric Oxide/analysis ; Pulmonary Disease, Chronic Obstructive/blood ; Pulmonary Disease, Chronic Obstructive/diagnosis ; Pulmonary Disease, Chronic Obstructive/epidemiology ; Respiratory Function Tests ; Smoking/epidemiology
    Chemical Substances Biomarkers ; Cell Adhesion Molecules ; Interleukin-17 ; POSTN protein, human ; Nitric Oxide (31C4KY9ESH) ; Immunoglobulin E (37341-29-0)
    Language English
    Publishing date 2017-12-01
    Publishing country England
    Document type Journal Article
    ZDB-ID 603816-5
    ISSN 1532-4303 ; 0277-0903
    ISSN (online) 1532-4303
    ISSN 0277-0903
    DOI 10.1080/02770903.2017.1391281
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Critical role of CD44 in antigen-induced Th2- but not Th17-madiated murine airway inflammation.

    Nishimura, Tomoe / Katoh, Shigeki / Mori, Akio / Ohtomo, Takayuki / Saeki, Mayumi / Hiroi, Takachika / Kaminuma, Osamu

    Allergology international : official journal of the Japanese Society of Allergology

    2016  Volume 65 Suppl, Page(s) S59–61

    MeSH term(s) Animals ; Antigens/immunology ; Bronchial Hyperreactivity/immunology ; Bronchial Hyperreactivity/metabolism ; Bronchial Hyperreactivity/pathology ; Eosinophils/immunology ; Eosinophils/metabolism ; Hyaluronan Receptors/metabolism ; Mice ; Neutrophils/immunology ; Neutrophils/metabolism ; Th17 Cells/immunology ; Th17 Cells/metabolism ; Th2 Cells/immunology ; Th2 Cells/metabolism
    Chemical Substances Antigens ; Hyaluronan Receptors
    Language English
    Publishing date 2016-09
    Publishing country England
    Document type Letter
    ZDB-ID 1336498-4
    ISSN 1440-1592 ; 1323-8930
    ISSN (online) 1440-1592
    ISSN 1323-8930
    DOI 10.1016/j.alit.2016.04.010
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Contribution of neuraminidase 3 to the differentiation of induced regulatory T cells.

    Kaminuma, Osamu / Katoh, Shigeki / Miyagi, Taeko / Watanabe, Nobumasa / Kitamura, Noriko / Nishimura, Tomoe / Saeki, Mayumi / Mori, Akio / Hiroi, Takachika

    Genes to cells : devoted to molecular & cellular mechanisms

    2018  Volume 23, Issue 2, Page(s) 112–116

    Abstract: Neuraminidase family enzymes that hydrolyze the terminal sialic acid linkage in biomolecules are involved in various immune responses. We previously showed that Th1 and Th2 cells differentially express several neuraminidases. Herein, the expression of ... ...

    Abstract Neuraminidase family enzymes that hydrolyze the terminal sialic acid linkage in biomolecules are involved in various immune responses. We previously showed that Th1 and Th2 cells differentially express several neuraminidases. Herein, the expression of neuraminidases in induced regulatory T (iTreg) cells was investigated in comparison with that in other T-cell subsets. Contrary to the tendency toward higher neuraminidase 1 mRNA expression in in vitro-differentiated Th2 cells, compared to Th1, Th17 and iTreg cells, we observed significantly higher expression of neuraminidase 3 (Neu3) in iTreg cells. Furthermore, the expression of Neu3 in FoxP3
    MeSH term(s) Animals ; Cell Differentiation ; Cells, Cultured ; Forkhead Transcription Factors/metabolism ; Gene Expression Regulation ; Male ; Mice ; Mice, Inbred BALB C ; Neuraminidase/genetics ; Neuraminidase/metabolism ; Spleen/cytology ; Spleen/metabolism ; T-Lymphocytes, Regulatory/cytology ; T-Lymphocytes, Regulatory/metabolism ; Th1 Cells/metabolism ; Th2 Cells/metabolism
    Chemical Substances Forkhead Transcription Factors ; Foxp3 protein, mouse ; Neu3 protein, mouse (EC 3.2.1.18) ; Neuraminidase (EC 3.2.1.18)
    Language English
    Publishing date 2018-02
    Publishing country England
    Document type Journal Article
    ZDB-ID 1330000-3
    ISSN 1365-2443 ; 1356-9597
    ISSN (online) 1365-2443
    ISSN 1356-9597
    DOI 10.1111/gtc.12553
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top